SCHEMBL9376129

SCHEMBL9376129

C=CCN1CCc2ccccc2C1(C)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 5/20 0.47
PRCP P42785 3/20 0.41
LMNA P02545 1/20 0.38
GAA P10253 1/20 0.38
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ESR1 P03372 2/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9374939 0.81 OPRM1 (0.43) SIGMAR1
SCHEMBL9374898 0.80 SIGMAR1 (0.48) SIGMAR1
SCHEMBL9375592 0.77 SIGMAR1 (0.41) SIGMAR1ADRA2A
Hydrochloric Acid SCHEMBL9376392 0.77 SIGMAR1 (0.51) SIGMAR1
Hydrochloric Acid SCHEMBL9374650 0.75 CHRM2 (0.49) SIGMAR1ADRA2AESR1
SCHEMBL9374100 0.73 SIGMAR1 (0.50) SIGMAR1
SCHEMBL9379947 0.73 SIGMAR1 (0.47) SIGMAR1
SCHEMBL9378962 0.73 SIGMAR1 (0.49) SIGMAR1LMNA
SCHEMBL9375377 0.72 SIGMAR1 (0.43) SIGMAR1ESR1
SCHEMBL9377826 0.70 SIGMAR1 (0.43) SIGMAR1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0336228-B1 Tetrahydroisoquinolines and tetrahydrobenzazepines and a process for the preparation thereof FUJISAWA PHARMACEUTICAL CO (JP) 1994-11-09 EP disclosed
US-5059608-A Anticonvulsants, antiischemic agents FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1991-10-22 US disclosed
EP-0336228-A1 Tetrahydroisoquinolines and tetrahydrobenzazepines and a process for the preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-10-11 EP disclosed